0001231919-25-000275.txt : 20251002 0001231919-25-000275.hdr.sgml : 20251002 20251001192333 ACCESSION NUMBER: 0001231919-25-000275 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251002 DATE AS OF CHANGE: 20251001 EFFECTIVENESS DATE: 20251002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ansa Biotechnologies, Inc. CENTRAL INDEX KEY: 0001816722 ORGANIZATION NAME: EIN: 830744780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-559539 FILM NUMBER: 251366110 BUSINESS ADDRESS: STREET 1: 1198 65TH STREET #250 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 9256908100 MAIL ADDRESS: STREET 1: 1198 65TH STREET #250 CITY: EMERYVILLE STATE: CA ZIP: 94608 D 1 primary_doc.xml X0708 D LIVE 0001816722 Ansa Biotechnologies, Inc. 1198 65TH STREET #250 EMERYVILLE CA CALIFORNIA 94608 9256908100 DELAWARE None None Corporation true Jason T. Gammack 1198 65th Street #250 Emeryville CA CALIFORNIA 94608 Executive Officer Director Daniel Lin-Arlow 1198 65th Street #250 Emeryville CA CALIFORNIA 94608 Executive Officer Director Yanniv Dorone 1198 65th Street #250 Emeryville CA CALIFORNIA 94608 Director Matthew McManus 1198 65th Street #250 Emeryville CA CALIFORNIA 94608 Director Chenny Zhang 1198 65th Street #250 Emeryville CA CALIFORNIA 94608 Director Sebastian Palluk 1198 65th Street #250 Emeryville CA CALIFORNIA 94608 Executive Officer Biotechnology Decline to Disclose 06b false 2024-06-28 true true false 0 55477037 45199665 10277372 false 39 0 0 0 false Ansa Biotechnologies, Inc. /s/ Jason T. Gammack Jason T. Gammack Chief Executive Officer 2025-10-01